Researchers have uncovered a genetic signature that predicts breast cancer patients' responses to the chemotherapy drug paclitaxel. They hope that the findings could be used to tailor treatment for the disease, and perhaps eventually other cancers. As the signature is linked with a ...
Please Login to read the full article.
